Literature DB >> 19996624

Anticoagulation for cerebral venous thrombosis with subarachnoid hemorrhage: a case report.

Mohamed Osama Hegazi1, Sherif Ahmed, Mohamed Gaber Sakr, Omar Ahmed Hassanien.   

Abstract

OBJECTIVES: To report the success of anticoagulation (AC) treatment in a case of cerebral venous thrombosis (CVT) with subarachnoid hemorrhage (SAH) in view of the limited evidence seen in the literature supporting such a treatment option. CLINICAL PRESENTATION AND INTERVENTION: A 38-year-old lady with CVT and SAH presented 12 h after the onset of symptoms. AC with low-molecular-weight heparin was started 4 days later, when the repeated brain CT showed regression of the SAH. Heparin was changed to warfarin, and she was asymptomatic over a 12-month follow-up period. DISCUSSION: In a limited number of small studies, AC has been found to be beneficial for cases of CVT with hemorrhagic complications. The proper time to start AC in such cases was not clearly defined, and a delay of 4-33 days was observed after the onset of symptoms. In cases of spontaneous intracranial hemorrhage (ICH) in general, active bleeding is usually confined to the first 6 h, and chances of hematoma enlargement are higher in the first 24 h. On the other hand, it has been advised to rule out a coincidental vascular malformation and to radiologically confirm regression (or at least non-progression) of the ICH before starting AC.
CONCLUSION: AC for cases of CVT may remain beneficial in the presence of SAH. The time to start AC for CVT with hemorrhagic complications is unclear; however, AC was successful when given 4 days after the onset of symptoms in our case. It may be wise to repeat CT after at least 24 h from the onset of symptoms (to confirm regression or at least non-progression of the ICH) before starting AC. It may also be prudent to perform magnetic resonance angiography, or digital subtraction angiography to rule out a coincidental intracranial aneurysm before AC. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996624     DOI: 10.1159/000252839

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  6 in total

1.  Diffuse Subarachnoid Hemorrhage Secondary to Cerebral Venous Sinus Thrombosis.

Authors:  Brian Anderson; Shyamsunder Sabat; Amit Agarwal; Krishnamoorthy Thamburaj
Journal:  Pol J Radiol       Date:  2015-06-01

2.  Perimesencephalic nonaneurysmal subarachnoid hemorrhage caused by transverse sinus thrombosis: A case report and review of literature.

Authors:  Fang-Wang Fu; Jie Rao; Yuan-Yuan Zheng; Liang Song; Wei Chen; Qi-Hui Zhou; Jian-Guang Yang; Jiang-Qiong Ke; Guo-Qing Zheng
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 3.  New Developments in the Pathophysiology, Workup, and Diagnosis of Dural Venous Sinus Thrombosis (DVST) and a Systematic Review of Endovascular Treatments.

Authors:  Sanjay Konakondla; Clemens M Schirmer; Fengwu Li; Xiaogun Geng; Yuchuan Ding
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

4.  Nonaneurysmal Perimesencephalic Subarachnoid Hemorrhage as an Atypical Initial Presentation of Cerebral Venous Sinus Thrombosis: A Case Report.

Authors:  Roaa R Amer; Eman A Bakhsh
Journal:  Am J Case Rep       Date:  2018-04-21

5.  Combined venous and arterial thrombosis revealing underlying myeloproliferative disorder in a young patient: a case report.

Authors:  Rime Benmalek; Hanane Mechal; Hatim Zahidi; Karim Mounaouir; Salim Arous; Mohamed El Ghali Benouna; Abdenasser Drighil; Rachida Habbal
Journal:  J Med Case Rep       Date:  2021-02-16

6.  Recurrent cerebral venous sinus thrombosis in a young man- A case report of JAK2-negative polycythemia vera.

Authors:  Akanksha Singh; Subodh Kumar Mahto; Jyotsana Prasad; Suman Sharma; Ashwani Kumar Malhotra
Journal:  J Family Med Prim Care       Date:  2019-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.